I am currently caring for a 74-year-old man with a 2-month history of progressive nephrotic syndrome and cholestatic jaundice. What are the most likely diagnoses to consider? This is a challenging ...

Expanded indication supported by mixed bag of trial data ...

The FDA granted full approval to sparsentan for proteinuria reduction in adults and pediatric patients aged at least 8 years ...

Idiopathic nephrotic syndrome is the most common disorder of glomerular function in pediatrics. [1] Approximately 40% of children diagnosed with idiopathic nephrotic syndrome will have a relapsing ...

Researchers sought to better understand the distinct immunological pathways in AAV and nephrotic syndrome, which could lead to better diagnosis. A better understanding of the distinct immunological ...

Travere Therapeutics Inc. TVTX shares are up on Tuesday following the announcement of full FDA approval for FILSPARI ...

Full FDA approval covers proteinuria reduction in FSGS without nephrotic syndrome, a defined clinical subset differentiated ...

Findings showed a greater proportion of patients achieved sustained complete remission with obinutuzumab vs mycophenolate mofetil at week 52. Topline data were announced from a phase 3 study ...

Travere Therapeutics TVTX shares surged 37.2% on Tuesday after the company announced that the FDA approved Filspari ...